[Immunosuppressive treatment of the early stages of active or inactive chronic hepatitis: results of a pilot study (author's transl)].
Immunosuppressive treatment with prednisolone and azathioprine was administered to a small group of nine patients in the early stage of chronic active or inactive hepatitis about six months after onset of the disease. There occurred a relatively rapid improvement in the active liver process, including biochemical and histological findings, compared with ten patients in a control group who, with the same liver condition, were not given immunosuppressive treatment. There were no side-effects in the treated group.
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D011239:Prednisolone; D001379:Azathioprine
Immunsuppressive Therapie von Frühformen der chronischen Hepatitis. Ergebnisse einer Pilot-Studie.